dc.contributor.author |
Ugarte Gil, Cesar Augusto |
|
dc.contributor.author |
Pearson, F. |
|
dc.contributor.author |
Moore, David Alexander James |
|
dc.contributor.author |
Critchley, J. |
|
dc.contributor.author |
van Crevel, R. |
|
dc.date.accessioned |
2019-08-08T15:23:45Z |
|
dc.date.available |
2019-08-08T15:23:45Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/7133 |
|
dc.description.abstract |
We thank Drs Yates and Barr for their valuable comments. In our article [1], we were not attempting to assess the extent to which dysglycemia is causally associated with tuberculosis (TB). A number of prospective studies exist, among a body of evidence, supporting probabilistic causation between diabetes mellitus (DM) and TB [2, 3]. Rather, the aim of our study was to identify age-adjusted prevalence and clinical characteristics of DM and intermediate hyperglycemia among those with newly diagnosed TB across 4 TB-endemic settings. In our South African population, the prevalence of DM (10.9% [95% confidence interval, 7%–14.9%]) was the... |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Oxford University Press |
|
dc.relation.ispartofseries |
Clinical Infectious Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
tuberculosis |
en_US |
dc.subject |
dysglycemia |
en_US |
dc.subject |
diabetes mellitus |
en_US |
dc.subject |
associated factors |
en_US |
dc.title |
Reply to Yates and Barr |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1093/cid/ciz434 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.08 |
|
dc.relation.issn |
1537-6591 |
|